Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
about
Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.Obesity and contraception.Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosingAn ethinyl estradiol-levonorgestrel containing oral contraceptive does not alter cytochrome P4502C9 in vivo activity.European society of contraception statement on contraception in obese women.Clarification of contraceptive drug pharmacokinetics in obesity.Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.17-β-Estradiol induces spreading depression and pain behavior in alert female rats.Levonorgestrel butanoate intramuscular injection does not reliably suppress ovulation for 90 days in obese and normal-BMI women: a pilot study.
P2860
Q30841046-881FCE17-4C0C-463F-8493-4425584FA624Q34266525-C20F67C2-F903-440F-8BE8-09E0AD37B81AQ34687906-423AC0F7-08B5-497B-8386-4B16C4B9D095Q34718314-81DFFCFF-F0E9-4891-B5CD-CB12E65156B6Q35174900-717E5AB2-0D95-437E-A449-B630A3EB7C6AQ37094764-172D2E0E-D513-4BB8-A064-C80BDC68288AQ37603880-CED7CAC9-8FDB-48D3-817C-8E734136D03EQ38266121-678037F4-E835-49E3-A4D7-F1747E1CD702Q38932206-5AA5A763-F398-4B6A-97EB-188CD6DAA74BQ39282698-88343754-6291-4DA3-810B-5F6254FE3BF4Q47548932-A43A5297-B193-4BC4-A070-9FD17DCAEE0EQ49549651-51F2EF5C-FAFE-4AB9-B287-CF61540F3E3F
P2860
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prolonged monitoring of ethiny ...... ese oral contraceptives users.
@en
Prolonged monitoring of ethiny ...... ese oral contraceptives users.
@nl
type
label
Prolonged monitoring of ethiny ...... ese oral contraceptives users.
@en
Prolonged monitoring of ethiny ...... ese oral contraceptives users.
@nl
prefLabel
Prolonged monitoring of ethiny ...... ese oral contraceptives users.
@en
Prolonged monitoring of ethiny ...... ese oral contraceptives users.
@nl
P2093
P2860
P1433
P1476
Prolonged monitoring of ethiny ...... bese oral contraceptives users
@en
P2093
Alison B Edelman
Barent Dubois
Frank Z Stanczyk
Martha McInnis
Myrna Y Munar
P2860
P304
P356
10.1016/J.CONTRACEPTION.2012.10.008
P577
2012-11-12T00:00:00Z